Form 8-K - Current report:
SEC Accession No. 0001193125-22-248711
Filing Date
2022-09-22
Accepted
2022-09-22 07:02:04
Documents
17
Period of Report
2022-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d322153d8k.htm   iXBRL 8-K 27679
2 EX-10.1 d322153dex101.htm EX-10.1 193427
3 EX-99.1 d322153dex991.htm EX-99.1 14182
7 GRAPHIC g322153g0922021412825.jpg GRAPHIC 5643
8 GRAPHIC g322153pmt18.jpg GRAPHIC 7306
9 GRAPHIC g322153pmt25.jpg GRAPHIC 4384
  Complete submission text file 0001193125-22-248711.txt   439812

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220919.xsd EX-101.SCH 2884
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220919_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220919_pre.xml EX-101.PRE 11280
11 EXTRACTED XBRL INSTANCE DOCUMENT d322153d8k_htm.xml XML 3389
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 221257817
SIC: 3841 Surgical & Medical Instruments & Apparatus